|
Market Closed -
NYSE
16:00:03 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 316.49 USD | +2.50% |
|
-2.99% | -6.29% |
| 09-15 | Cencora, Inc. Presents at 2026 Global Healthcare Conference, Sep-15-2026 03:10 PM | |
| 09-15 | Cencora, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 08:30 AM |
| Market Cap | 60.39B 52.66B 49.6B 45.17B 84.68B 5,786B 84.79B 594B 229B 2,947B 227B 222B 9,511B | P/E 2026 * |
17.3x | P/E 2027 * | 18.9x |
|---|---|---|---|---|---|
| Enterprise Value | 68.09B 59.36B 55.91B 50.92B 95.47B 6,523B 95.59B 670B 258B 3,323B 256B 250B 10,722B | EV / Sales 2026 * |
0.2x | EV / Sales 2027 * | 0.2x |
| Free-Float |
61.21% | Yield 2026 * |
0.75% | Yield 2027 * | 0.78% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| COR | Delayed | |
CBOE
| COR | Real-time | |
|
Mexican S.E.
| COR * | End-of-day quote | |
|
London S.E.
| 0HF3 | Delayed | |
|
Borsa Italiana
| 1COR | End-of-day quote | |
|
Berne S.E.
| ABG | End-of-day quote | |
|
Tradegate
| ABG | Real-time | |
|
Deutsche Boerse AG
| ABG | Delayed | |
|
Börse Stuttgart
| ABG | Delayed | |
|
Boerse Muenchen
| ABG | Real-time | |
|
Wiener Boerse
| ABC | End-of-day quote |
Last Transcript: Cencora, Inc.
| 1 day | +2.50% | ||
| 1 week | -2.99% | ||
| Current month | -2.20% | ||
| 1 month | -0.49% | ||
| 3 months | +16.43% | ||
| 6 months | -3.19% | ||
| Current year | -6.29% |
| 1 week | 304.45 |  | 323.98 |
| 1 month | 304.45 | | 338.71 |
| Current year | 244.82 | | 376.92 |
| 1 year | 244.82 | | 377.54 |
| 3 years | 178.21 | | 377.54 |
| 5 years | 113.68 | | 377.54 |
| 10 years | 68.38 | | 377.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Mauch
CEO | Chief Executive Officer | 59 | 2024-09-30 |
Eva Boratto
DFI | Director of Finance/CFO | 59 | 2026-06-28 |
Pawan Verma
CTO | Chief Tech/Sci/R&D Officer | 50 | 2024-11-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Lon Greenberg
BRD | Director/Board Member | 75 | 2013-05-15 |
Robert Mauch
BRD | Director/Board Member | 59 | 2024-09-30 |
D. Mark Durcan
CHM | Chairman | 64 | 2025-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/16/26 | Sell | Director | -1,280 | 0.0007% | ||
| 9/1/26 | Sell | Controller/Auditor | -985 | 0.0005% | ||
| 8/24/26 | Sell | General Counsel | -11,300 | 0.0058% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.50% | -2.99% | +9.13% | +71.14% | 60.39B | |
| +0.36% | -0.11% | -24.30% | +4.09% | 178B | |
| -0.41% | -2.19% | -3.50% | +14.03% | 117B | |
| -0.13% | -1.21% | -3.39% | -31.82% | 49.22B | |
| -0.22% | +0.78% | +10.27% | +47.46% | 48.02B | |
| -0.20% | +5.30% | +32.20% | +0.10% | 33.65B | |
| +1.01% | -1.93% | - | - | 28.04B | |
| -0.15% | +1.85% | +41.96% | -3.34% | 25.46B | |
| -0.79% | +5.26% | +8.20% | -12.97% | 22.5B | |
| -2.33% | -1.08% | -8.97% | +8.33% | 20.96B | |
| Average | -0.04% | +1.04% | +6.84% | +10.78% | 58.38B | |
| Weighted average by Cap. | +0.17% | -0.14% | -3.09% | +12.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 337B 294B 277B 252B 473B 32,302B 473B 3,316B 1,278B 16,455B 1,267B 1,238B 53,097B | 353B 308B 290B 264B 495B 33,829B 496B 3,473B 1,338B 17,233B 1,326B 1,297B 55,608B |
| Net income | 3.58B 3.12B 2.94B 2.68B 5.02B 343B 5.03B 35.21B 13.57B 175B 13.45B 13.15B 564B | 2.84B 2.48B 2.34B 2.13B 3.99B 273B 3.99B 27.98B 10.78B 139B 10.69B 10.45B 448B |
| Net Debt | 7.69B 6.71B 6.32B 5.75B 10.78B 737B 10.8B 75.63B 29.15B 375B 28.89B 28.25B 1,211B | 9.44B 8.23B 7.75B 7.06B 13.23B 904B 13.25B 92.8B 35.77B 461B 35.45B 34.66B 1,486B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-21 | US$316.49 | +2.50% | 1,049,948 |
| 26-09-18 | US$308.78 | -0.20% | 3,344,625 |
| 26-09-17 | US$309.41 | -2.85% | 1,098,496 |
| 26-09-16 | US$318.50 | -1.48% | 931,141 |
| 26-09-15 | US$323.29 | -0.90% | 913,496 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COR Stock
Select your edition
All financial news and data tailored to specific country editions
